Short after a fund raising, Medivis (New York) annonces that SurgicalAR plateform gets now the 510(K) Clearance from FDA. This “Premarket Notification” allows Medivis to deploy this solution across United States territory and increased the number of studies on its effectiveness.
Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has received 510(k) clearance for clinical use in the operating room by the U.S. Food and Drug Administration (FDA). The New York City-based medical technology company will commence the immediate commercialization of the platform in the United States.
Source: Medivis SurgicalAR Gets FDA Clearance | DAIC
